Literature DB >> 29705950

The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives.

Marta Pinto-Grau1,2, Orla Hardiman3, Niall Pender3,4.   

Abstract

Amyotrophic Lateral Sclerosis is a neurodegenerative disorder characterized primarily by motor network disruption. Extra-motor manifestations including executive functions, social cognition, and behavioral changes are now well recognized as important features of ALS, and are associated with frontotemporal and frontostriatal network disruption. However, the presence and characterization of language changes has received less attention. This systematic review characterizes the profile of reported language dysfunction in ALS. PRISMA guidelines were implemented to carry out and report the review. Current evidence suggests that areas of neuroanatomical disruption in ALS spread to language centers such as posterior, inferior frontal and superior temporal areas leading to deficits in word retrieval, syntactic and grammatical processing, and spelling. However, the majority of studies of language in ALS have been limited by the recruitment of small clinic-based prevalent samples and important questions remain regarding the incidence and progression of language impairment in ALS. Further studies from population-based incident cohorts will help to determine the range of language deficits in ALS, and how these relate to previously defined executive and behavioral sub-phenotypes.

Entities:  

Keywords:  Amyotrophic Lateral Sclerosis (ALS); Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder (ALS-FTSD); Cognition; Frontotemporal Dementia (FTD); Language; Systematic review

Mesh:

Year:  2018        PMID: 29705950     DOI: 10.1007/s11065-018-9375-7

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  95 in total

Review 1.  The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis.

Authors:  Joost Raaphorst; Marianne de Visser; Wim H J P Linssen; Rob J de Haan; Ben Schmand
Journal:  Amyotroph Lateral Scler       Date:  2010

2.  Action verb comprehension in amyotrophic lateral sclerosis and Parkinson's disease.

Authors:  Collin York; Christopher Olm; Ashley Boller; Leo McCluskey; Lauren Elman; Jenna Haley; Emily Seltzer; Lama Chahine; John Woo; Katya Rascovsky; Corey McMillan; Murray Grossman
Journal:  J Neurol       Date:  2014-03-28       Impact factor: 4.849

3.  The Spot-the-Word test: a robust estimate of verbal intelligence based on lexical decision.

Authors:  A Baddeley; H Emslie; I Nimmo-Smith
Journal:  Br J Clin Psychol       Date:  1993-02

4.  The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.

Authors:  J J Kew; L H Goldstein; P N Leigh; S Abrahams; N Cosgrave; R E Passingham; R S Frackowiak; D J Brooks
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

5.  Cognitive change in ALS: a prospective study.

Authors:  S Abrahams; P N Leigh; L H Goldstein
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

6.  Writing errors in ALS related to loss of neuronal integrity in the anterior cingulate gyrus.

Authors:  Ichiro Yabe; Sachiko Tsuji-Akimoto; Tohru Shiga; Shinsuke Hamada; Kenji Hirata; Mika Otsuki; Yuji Kuge; Nagara Tamaki; Hidenao Sasaki
Journal:  J Neurol Sci       Date:  2012-01-04       Impact factor: 3.181

7.  Cognitive changes predict functional decline in ALS: a population-based longitudinal study.

Authors:  Marwa Elamin; Peter Bede; Susan Byrne; Norah Jordan; Laura Gallagher; Brona Wynne; Caoimhe O'Brien; Julie Phukan; Catherine Lynch; Niall Pender; Orla Hardiman
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

8.  Cognitive impairment in motor neuron disease.

Authors:  R Gallassi; P Montagna; C Ciardulli; S Lorusso; V Mussuto; A Stracciari
Journal:  Acta Neurol Scand       Date:  1985-06       Impact factor: 3.209

9.  Production of verbs related to body movement in amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD).

Authors:  Katheryn A Q Cousins; Sharon Ash; Murray Grossman
Journal:  Cortex       Date:  2017-09-08       Impact factor: 4.027

10.  Examining the language and behavioural profile in FTD and ALS-FTD.

Authors:  Jennifer A Saxon; Jennifer C Thompson; Matthew Jones; Jennifer M Harris; Anna Mt Richardson; Tobias Langheinrich; David Neary; David Ma Mann; Julie S Snowden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-06-08       Impact factor: 10.154

View more
  10 in total

1.  Speech network regional involvement in bulbar ALS: a multimodal structural MRI study.

Authors:  Sanjana Shellikeri; Matthew Myers; Sandra E Black; Agessandro Abrahao; Lorne Zinman; Yana Yunusova
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-05-14       Impact factor: 4.092

Review 2.  Cognitive and behavioral involvement in ALS has been known for more than a century.

Authors:  Stefano Zago; Lorenzo Lorusso; Edoardo N Aiello; Martino Ugolini; Barbara Poletti; Nicola Ticozzi; Vincenzo Silani
Journal:  Neurol Sci       Date:  2022-09-02       Impact factor: 3.830

3.  Identifying key signs of motor neurone disease in primary care: a nested case-control study using the QResearch database.

Authors:  Xue W Mei; Judith Burchardt; Tom A Ranger; Christopher J McDermott; Aleksandar Radunovic; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

4.  Patterns of Language Impairment in Early Amyotrophic Lateral Sclerosis.

Authors:  Marta Pinto-Grau; Bronagh Donohoe; Sarah O'Connor; Lisa Murphy; Emmet Costello; Mark Heverin; Alice Vajda; Orla Hardiman; Niall Pender
Journal:  Neurol Clin Pract       Date:  2021-10

5.  Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.

Authors:  Giulia Vinceti; Nicholas Olney; Maria Luisa Mandelli; Salvatore Spina; H Isabel Hubbard; Miguel A Santos-Santos; Christa Watson; Zachary A Miller; Catherine Lomen-Hoerth; Paolo Nichelli; Bruce L Miller; Lea T Grinberg; William W Seeley; Maria Luisa Gorno-Tempini
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-01-22       Impact factor: 4.092

Review 6.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

Review 7.  Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis.

Authors:  Foteini Christidi; Efstratios Karavasilis; Michail Rentzos; Nikolaos Kelekis; Ioannis Evdokimidis; Peter Bede
Journal:  Front Neurol       Date:  2018-11-22       Impact factor: 4.003

8.  Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder.

Authors:  Syeda Fabeha Husain; Rongjun Yu; Tong-Boon Tang; Wilson W Tam; Bach Tran; Travis T Quek; Shi-Hui Hwang; Cheryl W Chang; Cyrus S Ho; Roger C Ho
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

9.  Unimpaired Neuropsychological Performance and Enhanced Memory Recall in Patients with Sbma: A Large Sample Comparative Study.

Authors:  S Marcato; J R Kleinbub; G Querin; E Pick; I Martinelli; C Bertolin; S Cipolletta; E Pegoraro; G Sorarù; A Palmieri
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

Review 10.  Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies.

Authors:  David Reyes-Leiva; Oriol Dols-Icardo; Sonia Sirisi; Elena Cortés-Vicente; Janina Turon-Sans; Noemi de Luna; Rafael Blesa; Olivia Belbin; Victor Montal; Daniel Alcolea; Juan Fortea; Alberto Lleó; Ricard Rojas-García; Ignacio Illán-Gala
Journal:  Front Neurol       Date:  2022-01-18       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.